Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

ESTIMATING R0 OF SARS-COV-2 IN HEALTHCARE SETTINGS

View ORCID ProfileLaura Temime, View ORCID ProfileMarie-Paule Gustin, View ORCID ProfileAudrey Duval, View ORCID ProfileNiccolò Buetti, View ORCID ProfilePascal Crépey, View ORCID ProfileDidier Guillemot, View ORCID ProfileRodolphe ThiéBaut, View ORCID ProfilePhilippe Vanhems, View ORCID ProfileJean-Ralph Zahar, View ORCID ProfileDavid R.M. Smith, View ORCID ProfileLulla Opatowski
doi: https://doi.org/10.1101/2020.04.20.20072462
Laura Temime
1MESuRS laboratory, Conservatoire national des arts et métiers, Paris, France; PACRI Unit, Institut Pasteur, Conservatoire national des arts et métiers, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laura Temime
  • For correspondence: laura.temime{at}lecnam.net
Marie-Paule Gustin
2Institute of Pharmaceutic and Biological Sciences, University Claude Bernard Lyon 1, Villeurbanne, France; Emerging Pathogens Laboratory-Fondation Mérieux, International Center for Infectiology Research (CIRI), Inserm U1111, CNRS UMR5308, ENS de Lyon, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marie-Paule Gustin
Audrey Duval
3Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France; Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion unit, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Audrey Duval
Niccolò Buetti
4INSERM IAME, U1137, Team DesCID, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Niccolò Buetti
Pascal Crépey
5UPRES-EA 7449 REPERES « Recherche en Pharmaco-Epidémiologie et Recours aux Soins » – EHESP – Université de Rennes, Rennes, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pascal Crépey
Didier Guillemot
6Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France; Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion unit, Paris, France; AP-HP Paris Saclay, Public Health, Medical Information, Clinical research, Le Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Didier Guillemot
Rodolphe ThiéBaut
7INSERM U1219 Bordeaux Population Health, Université de Bordeaux, Bordeaux, France; INRIA SISTM team, Talence, France; Vaccine Research Institute, Créteil, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rodolphe ThiéBaut
Philippe Vanhems
8Emerging Pathogens Laboratory-Fondation Mérieux, International Center for Infectiology Research (CIRI), Inserm U1111, CNRS UMR5308, ENS de Lyon, Lyon, France; Service d’Hygiène, Epidémiologie et Prévention, Hospices Civils de Lyon, F-69437, Lyon, France; Inserm, F-CRIN, Réseau Innovative Clinical Research in Vaccinology (I-REIVAC), Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Philippe Vanhems
Jean-Ralph Zahar
9IAME, UMR 1137, Université Paris 13, Sorbonne Paris Cité, France; Service de Microbiologie Clinique et Unité de Contrôle et de Prévention du Risque Infectieux, Groupe Hospitalier Paris Seine Saint-Denis, AP-HP, Bobigny, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jean-Ralph Zahar
David R.M. Smith
10Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France; Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion unit, Paris, France; MESuRS laboratory, Conservatoire national des arts et métiers, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David R.M. Smith
Lulla Opatowski
11Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France; Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion unit, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lulla Opatowski
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

To date, no specific estimate of R0 for SARS-CoV-2 is available for healthcare settings. Using inter-individual contact data, we highlight that R0 estimates from the community cannot translate directly to healthcare settings, with pre-pandemic R0 values ranging 1.3-7.7 in three illustrative healthcare institutions. This has implications for nosocomial Covid-19 control.

In the context of the current Covid-19 pandemic, the basic reproduction number R0 has been recognized as a key parameter to characterize epidemic risk and predict spread of SARS-CoV-2, the causative virus of Covid-19 infection [1]. R0 describes the average number of secondary cases generated by an initial index case in an entirely susceptible population. R0 is determined not only by the inherent infectiousness of a pathogen, but also environmental conditions, host contact behaviours and other factors that influence transmission. Understanding the evolution of the effective reproduction number Rt, which describes R0 as it varies over time, is also essential for epidemiological forecasting and to assess the impact of control strategies [2, 3].

Over recent months, numerous estimates of R0 for SARS-CoV-2 have been computed through analysis of reported infections from countries all over the world [2, 4-6], as well as in specific subpopulations, such as individuals aboard the Diamond Princess cruise ship [7]. Published estimates mostly range from 2-4.

However, to date, no estimates of R0 specific to healthcare settings have been published.

Healthcare institutions are confronted with several urgent and overlapping challenges linked to Covid-19. Acute care facilities face unprecedented demand for beds and resources to accommodate Covid-19 patients, particularly in intensive care units in high-prevalence regions. Introduction of SARS-CoV-2 to healthcare settings can further result in nosocomial outbreaks, with superspreading events already reported in some hospitals [8], as was also observed for SARS-CoV and MERS-CoV. In addition to risks for patients, whose underlying conditions put them at greater risk of severe infection, there is also an important risk of infection among healthcare workers [8].

Contacts between individuals are fundamental to the spread of respiratory pathogens like SARS-CoV-2, and contact patterns in healthcare settings are highly context-specific. Contacts between patients and healthcare workers tend to be simultaneously more frequent, longer and more at-risk than contacts occurring in the community. This could translate to higher R0 values, as underlined in earlier work on other coronaviruses, in which R0 was estimated to be much higher in hospitals than in the community [9].

Here, using detailed individual-level contact pattern data from both the community and three healthcare institutions in France, we explore how the reproduction number estimated in the community translates to these institutions, and discuss potential consequences for public health.

METHODS

Under simplifying assumptions, R0 can be estimated as follows: Embedded Image where p is the probability of transmission per minute spent in contact, dCtc is the average contact duration (in minutes), nCtc is the average number of contacts per person per day, and dInf is the average duration of infectivity (in days): approximately 10 days for Covid-19 [10].

Assuming that p and dInf are the same for individuals in the community and in healthcare settings, we can translate the previous expression into setting-specific R0 values computed as:

  • In the community:Embedded Image

  • In the healthcare settings:Embedded Image

where superscripts C and H denote values for community and healthcare settings, respectively.

The healthcare setting-specific reproduction number may then be estimated from the community-specific reproduction number and the contact pattern characteristics in both settings, as: Embedded Image

NUMERICAL APPLICATION IN THE FRENCH CONTEXT

Based on detailed inter-individual contact data from France [11], in the community the median number of inter-individual contacts per person is Embedded Image contacts/day and the median duration of these contacts ranges from 15 minutes to 1 hour. For simplicity, in the following we use Embedded Image minutes.

The reproduction number for SARS-CoV-2 has been estimated in the French community at values ranging from Embedded Image to 4 [2, 12, 13]. In the following we use Embedded Image.

These translate to an average transmission risk per minute spent in contact of: Embedded Image

Table 1 provides estimates of the healthcare setting-specific reproduction numberEmbedded Image, depending on the average number of daily contacts within the healthcare setting Embedded Image, and the actual value of Embedded Image. The mean duration of daily contacts within the healthcare setting Embedded Image is assumed to range from 10 to 40 minutes.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Range of estimated reproduction numbers Embedded Image values obtained when Embedded Image ranges from 10 to 40 minutes, for different assumed values of Embedded Image (rows) and Embedded Image (columns)

THREE ILLUSTRATIVE EXAMPLES

As an illustration, we used detailed contact data from three different healthcare settings in France during the pre-pandemic period to estimate Embedded Image in the absence of control measures specific to Covid-19:

  • For a 170-bed rehabilitation hospital [14], where Embedded Image contacts/day and Embedded Image min, the pre-pandemic Embedded Image is estimated as Embedded Image

  • For an acute-care geriatric unit [15], where the cumulative time spent in contact with others per individual per day was Embedded Image, the pre-pandemic Embedded Image is estimated as Embedded Image

  • For a 100-bed nursing home [16], where the cumulative time spent in contact per individual and per day was Embedded Image, the pre-pandemic Embedded Image is estimated as

Embedded Image

DISCUSSION

Estimating R0 has been an important focus of epidemiological work to understand the transmission dynamics and pandemic trajectory of SARS-CoV-2. We highlight here that reproduction numbers estimated in the community cannot be translated directly to healthcare settings, where inter-individual contact patterns are specific to and variable between institutions.

Health care institutions are at high risk of SARS-CoV-2 importation, from admission of infected patients or from visitors or healthcare workers infected in the community. Our estimates of Embedded Image suggest that, depending on a healthcare facility’s size and structure, the risk of nosocomial spread may be much higher or lower than in the general population, with values ranging from 0.4 to 13.3 (Table 1).

Our results have implications for Covid-19 infection prevention and control. In healthcare settings with estimated low values of pre-pandemic Embedded Image, it is expected that classical barrier measures – reducing p, the probability of transmission per minute of contact – will suffice to prevent the spread of the virus. On the contrary, in healthcare settings where the estimated pre-pandemic Embedded Image is high, it is critical to implement additional control measures. These measures could include reducing the frequency Embedded Image and duration Embedded Image of contacts (e.g. through limiting patient-patient contacts by cancelling social activities and gatherings), limiting patient transfers, or reorganizing human resources and provisioning of care within the institution.

It should be underlined that this work’s aim is to present a conceptual discussion about R0 in healthcare settings. Hence, the elements presented here, and in particular the numerical estimates, should be interpreted in light of the following over-simplifications.

First, Covid-19 infection was simplified by assuming the same duration of infectivity, irrespective of the setting. However, in the community, individuals presenting symptoms may isolate themselves and stay at home whereas patients of healthcare settings will stay hospitalized. Considering such differences would lead to higher estimates of Embedded Image.

Second, we assumed the same per-minute probability of transmission, irrespective of the setting and nature of contacts. However, some hospital contacts, such as those involving close proximity or invasive procedures, may pose greater transmission risk than others. Also, a higher concentration of severe infections, which may shed more virus [17], and the presence of immunosuppressed individuals, may entail a higher transmission probability in hospitals, therefore increasing Embedded Image.

Third, Embedded Image may differ according to individual characteristics, notably for patients vs. healthcare workers. In addition, some individuals may be super-contactors or super-shedders, with a greater probability of generating secondary cases if infected.

Last, our R0 formula assumes random homogenous mixing between individuals in the population. For hospital networks, which are highly clustered due to ward structure and occupational hierarchies, this formula could be refined. Computing Embedded Image values using contact information at the ward level should facilitate more accurate estimates. Additionally, our formula makes the assumption that transmission risk increases linearly with contact duration, which may not be correct, especially for very long contacts. For instance, censoring contacts longer than 1 hour in the data from the first example gives an average contact duration within the facility of 15 min, leading to a lower estimated Embedded Image of 3.37.

In conclusion, pandemic Covid-19 continues to overwhelm healthcare institutions with critically ill and highly infectious patients, and nosocomial outbreaks pose great risk to patients and healthcare workers alike. Understanding how transmission risk varies between community and healthcare settings, and within and between different healthcare institutions such as hospitals and long-term care facilities, is fundamental to better predict risks of nosocomial outbreaks and inform appropriate infection control measures.

Data Availability

All the data referred to in the manuscript comes from published papers.

FUNDING

This work was funded in part by the French government through the National Research Agency projects SPHINX (# 17-CE36-0008-01) and MOD-COV. DS is also supported by a Canadian Institutes for Health Research doctoral foreign study award (Funding Reference Number 164263).

Footnotes

  • On behalf of the “Modelling COVID-19 in hospitals” REACTinG AVIESAN working group: Niccolò Buetti, Christian Brun-Buisson, Sylvie Burban, Simon Cauchemez, Guillaume Chelius, Anthony Cousien, Pascal Crepey, Vittoria Colizza, Christel Daniel, Aurélien Dinh, Pierre Frange, Eric Fleury, Antoine Fraboulet, Didier Guillemot, Marie-Paule Gustin, Bich-Tram Huynh, Lidia Kardas-Sloma, Elsa Kermorvant, Jean Christophe Lucet, Lulla Opatowski, Chiara Poletto, Laura Temime, Rodolphe Thiebaut, Sylvie van der Werf, Philippe Vanhems, Linda Wittkop, Jean-Ralph Zahar.

REFERENCES

  1. 1.↵
    Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet 2020; 395(10228): 931–4.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Flaxman S, Mishra S, Gandy A, et al. Report 13: Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries, 2020.
  3. 3.↵
    Pan A, Liu L, Wang C, et al. Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China. Jama 2020.
  4. 4.↵
    Kucharski AJ, Russell TW, Diamond C, et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect Dis 2020.
  5. 5.
    Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science 2020.
  6. 6.↵
    Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis 2020; 26(7).
  7. 7.↵
    Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis. Int J Infect Dis 2020; 93: 201–4.
    OpenUrlCrossRefPubMed
  8. 8.↵
    Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Jama 2020.
  9. 9.↵
    Hsieh YH. 2015 Middle East Respiratory Syndrome Coronavirus (MERS-CoV) nosocomial outbreak in South Korea: insights from modeling. PeerJ 2015; 3: e1505.
    OpenUrlCrossRefPubMed
  10. 10.↵
    Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020.
  11. 11.↵
    Béraud G, Kazmercziak S, Beutels P, et al. The French Connection: The First Large Population- Based Contact Survey in France Relevant for the Spread of Infectious Diseases. PLoS One 2015; 10(7): e0133203.
    OpenUrlCrossRefPubMed
  12. 12.↵
    Alizon S, Bénéteau T, Choisy M, et al. Estimating the basic reproduction number of the COVID-19 epidemic in France, 2020.
  13. 13.↵
    Di Domenico L, Pullano G, Sabbatini C, Boëlle P-Y, Colizza V. Expected impact of lockdown in Île-de-France and possible exit strategies, 2020.
  14. 14.↵
    Duval A, Obadia T, Martinet L, et al. Measuring dynamic social contacts in a rehabilitation hospital: effect of wards, patient and staff characteristics. Sci Rep 2018; 8(1): 1686.
    OpenUrl
  15. 15.↵
    Voirin N, Payet C, Barrat A, et al. Combining high-resolution contact data with virological data to investigate influenza transmission in a tertiary care hospital. Infect Control Hosp Epidemiol 2015; 36(3): 254–60.
    OpenUrlCrossRefPubMed
  16. 16.↵
    Assab R, Temime L. The role of hand hygiene in controlling norovirus spread in nursing homes. BMC Infect Dis 2016; 16: 395.
    OpenUrl
  17. 17.↵
    Xu K, Chen Y, Yuan J, et al. Factors associated with prolonged viral RNA shedding in patients with COVID-19. Clin Infect Dis 2020.
Back to top
PreviousNext
Posted April 24, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
ESTIMATING R0 OF SARS-COV-2 IN HEALTHCARE SETTINGS
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
ESTIMATING R0 OF SARS-COV-2 IN HEALTHCARE SETTINGS
Laura Temime, Marie-Paule Gustin, Audrey Duval, Niccolò Buetti, Pascal Crépey, Didier Guillemot, Rodolphe ThiéBaut, Philippe Vanhems, Jean-Ralph Zahar, David R.M. Smith, Lulla Opatowski
medRxiv 2020.04.20.20072462; doi: https://doi.org/10.1101/2020.04.20.20072462
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
ESTIMATING R0 OF SARS-COV-2 IN HEALTHCARE SETTINGS
Laura Temime, Marie-Paule Gustin, Audrey Duval, Niccolò Buetti, Pascal Crépey, Didier Guillemot, Rodolphe ThiéBaut, Philippe Vanhems, Jean-Ralph Zahar, David R.M. Smith, Lulla Opatowski
medRxiv 2020.04.20.20072462; doi: https://doi.org/10.1101/2020.04.20.20072462

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)